China National Accord Medicines Corporation Ltd. (SHE:000028)
China flag China · Delayed Price · Currency is CNY
24.53
+0.01 (0.04%)
May 8, 2026, 3:04 PM CST

SHE:000028 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
72,30872,77873,67574,84472,70167,648
Other Revenue
637.52637.52703633.35742.57710.01
72,94673,41674,37875,47773,44368,358
Revenue Growth (YoY)
-0.86%-1.29%-1.46%2.77%7.44%14.60%
Cost of Revenue
65,26665,61866,18066,47164,56160,372
Gross Profit
7,6807,7978,1989,0068,8837,986
Selling, General & Admin
5,7215,8116,4076,4046,3745,772
Research & Development
15.5819.9924.5526.829.07-
Other Operating Expenses
158.82161.93116.393.73180.1139.09
Operating Expenses
5,9806,0776,6426,5966,5855,955
Operating Income
1,7001,7201,5562,4112,2982,031
Interest Expense
-194.5-194.5-258.3-248.38-261.91-288.04
Interest & Investment Income
243.02264.56300.32314.58212.07366.68
Currency Exchange Gain (Loss)
1.371.37-1.852.95-0.440.41
Other Non Operating Income (Expenses)
-61.87-43.62-28.62-27.9-1.89-4.87
EBT Excluding Unusual Items
1,6881,7481,5682,4522,2452,105
Impairment of Goodwill
-253.92-253.92-887.85--38.98-162.69
Gain (Loss) on Sale of Investments
3.133.13-22.81-15.1628.87-
Gain (Loss) on Sale of Assets
5.77.9611.8745.318.314.25
Asset Writedown
-31.4-31.84-84-0.64-18.87-75.55
Legal Settlements
-0.31-0.31-0.51-3.25-0.05-0.55
Other Unusual Items
3636-9.16-5.1286.36104.09
Pretax Income
1,4481,509575.472,4732,3111,975
Income Tax Expense
361.72380.67338.47514.74539.33447.21
Earnings From Continuing Operations
1,0861,1282371,9581,7721,528
Minority Interest in Earnings
9.567.58405.49-359.23-285.03-191.21
Net Income
1,0951,136642.491,5991,4871,336
Net Income to Common
1,0951,136642.491,5991,4871,336
Net Income Growth
88.30%76.80%-59.82%7.57%11.24%-4.67%
Shares Outstanding (Basic)
556557559557557557
Shares Outstanding (Diluted)
556557559557557557
Shares Change (YoY)
-0.54%-0.38%0.26%0.12%--
EPS (Basic)
1.972.041.152.872.672.40
EPS (Diluted)
1.972.041.152.872.672.40
EPS Growth
89.24%77.39%-59.93%7.49%11.25%-4.59%
Free Cash Flow
340.511,4212,9892,6152,2381,285
Free Cash Flow Per Share
0.612.555.354.694.022.31
Dividend Per Share
0.6160.6160.3660.6800.6150.462
Dividend Growth
68.31%68.31%-46.18%10.50%33.35%-25.01%
Gross Margin
10.53%10.62%11.02%11.93%12.09%11.68%
Operating Margin
2.33%2.34%2.09%3.19%3.13%2.97%
Profit Margin
1.50%1.55%0.86%2.12%2.02%1.96%
Free Cash Flow Margin
0.47%1.94%4.02%3.46%3.05%1.88%
EBITDA
1,5791,9323,1023,8362,5422,239
EBITDA Margin
2.17%2.63%4.17%5.08%3.46%3.28%
D&A For EBITDA
-121.32212.011,5451,426244.32207.45
EBIT
1,7001,7201,5562,4112,2982,031
EBIT Margin
2.33%2.34%2.09%3.19%3.13%2.97%
Effective Tax Rate
24.99%25.23%58.82%20.81%23.34%22.64%
Revenue as Reported
73,41673,41674,37875,477--
Advertising Expenses
----46.6744.12
Source: S&P Global Market Intelligence. Standard template. Financial Sources.